New biologic drug ASKG915 enters human trials for Hard-to-Treat cancers
Disease control
Recruiting now
This study tests a new biologic drug called ASKG915, given alone or with standard chemotherapy, in about 594 people with advanced solid tumors that have stopped responding to other treatments. The main goals are to check safety and find the best dose. The trial is currently recru…
Phase: PHASE1, PHASE2 • Sponsor: AskGene Pharma, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC